Skip to content

Interstitial Lung Disease

We are recognized for our specialized research and treatment programs in Interstitial Lung Disease (ILD), which encompasses a variety of disorders affecting the lung’s connective tissue. This research involves collaborative efforts to uncover novel therapies and better diagnostic tools, with the goal of slowing disease progression and improving the quality of life for those affected. Here is an overview of our ILD research programs:

  • Interstitial Lung Disease Center: The ILD Center provides comprehensive care and innovative research on interstitial lung diseases. The center integrates clinical care with cutting-edge research to address the needs of ILD patients.
  • Research Programs: Our researchers conduct studies on various types of ILD, including idiopathic pulmonary fibrosis (IPF), sarcoidosis and other interstitial pneumonias. They investigate the underlying mechanisms of ILD, focusing on the role of fibrosis, inflammation and genetic factors in disease development and progression.
  • Collaborative Research: Scientists collaborate with other research institutions, pharmaceutical companies and academic centers to advance ILD research. These collaborations help leverage a broad range of expertise and resources. Our physician-scientists participate in and lead multicenter studies to gather broader data and test new approaches.
  • Clinical Trials and Novel Diagnostics and Treatments: We are involved in clinical trials testing new drugs, biologics, and other treatments for ILD, including trials for antifibrotic agents, immunomodulatory drugs, and other innovative therapies. Research also focuses on developing and validating new diagnostic tools and biomarkers to improve the accuracy of ILD diagnosis and monitor disease progression.
  • ILD Research Advancements: Discovery of genetic mutations that increase the risk of developing pulmonary fibrosis. Clinical trials for the two new therapeutics approved to treat idiopathic pulmonary fibrosis (IPF).
  • David Baraghoshi

    David Baraghoshi, PhD

  • James P. Bridges

    James P. Bridges, PhD

  • Kevin K. Brown

    Kevin K. Brown, MD

  • Carlyne D. Cool

    Carlyne D. Cool, MD

  • James L. Crooks

    James L. Crooks, PhD, MS

  • Hans Dooms

    Hans Dooms, PhD

  • Gregory P. Downey

    Gregory P. Downey, MD, FRCPC

  • Evans Fernández

    Evans Fernández, MD, MS

  • Tasha E. Fingerlin

    Tasha E. Fingerlin, PhD

  • Jessica Galant-Swafford

    Jessica Galant-Swafford, MD

  • Steve D. Groshong

    Steve D. Groshong, MD, PhD

  • Tristan J. Huie

    Tristan J. Huie, MD

  • Stephen M. Humphries

    Stephen M. Humphries, PhD

  • William J. Janssen

    William J. Janssen, MD

  • Rebecca C. Keith

    Rebecca C. Keith, MD

  • Li Li

    Li Li, MD, PhD

  • Lisa A. Maier

    Lisa A. Maier, MD, MSPH, FCCP, ATSF

  • Mehrnaz Maleki Fischbach

    Mehrnaz Maleki Fischbach, MD

  • Karina Mora Massad

    Karina Mora Massad, MD

  • Alexandra McCubbrey

    Alexandra McCubbrey, PhD

  • Richard T. Meehan

    Richard T. Meehan, MD, FACP

  • Camille M. Moore

    Camille M. Moore, PhD

  • Elizabeth F. Redente

    Elizabeth F. Redente, PhD

  • R. Lee Reinhardt

    R. Lee Reinhardt, PhD

  • David W H Riches

    David W H Riches, PhD

  • Cecile S. Rose

    Cecile S. Rose, MD, MPH

  • Joshua J. Solomon

    Joshua J. Solomon, MD

  • Matthew J. Strand

    Matthew J. Strand, PhD

  • Soonho Yoon

    Soonho Yoon, MD, PhD